Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues.
A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasis, and prolongs survival with virtually no toxicity, researchers from The University of Texas M. D. Anderson Cancer Center report in the July 9 edition of Cancer Cell.
Fever, arthritis, and other symptoms occurring in people to who have recently traveled to islands in the Indian Ocean may signal infection with an imported virus called “chikungunya,” reports a study in the May/June issue of the journal Medicine?, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Although a number of studies have suggested that regular exercise reduces inflammation ? a condition that is predictive of cardiovascular and other diseases, such as diabetes ? it is still not clear whether there is a definitive link. And if such a link exists, the nature of the relationship is by no means fully understood.
Researchers at the University of New South Wales (UNSW) believe that blood may hold vital insights into what is happening in the brain of patients with chronic fatigue syndrome (CFS).
The National Institutes of Health has awarded $1.7 million to a University of Cincinnati scientist for molecular research that could lead to better treatments for brain injury patients.
Production of a protein that promotes inflammation appears to be linked to the higher incidence of liver cancer in men than in women, researchers at the University of California, San Diego School of Medicine have determined in mouse studies.
Variations in two genes related to inflammation may be a major risk factor for developing lung cancer, according to a team of scientists from the National Cancer Institute and the University of Texas M. D. Anderson Cancer Center.
We?ve all wondered how a seemingly healthy person can actually be at high risk for heart disease or a heart attack. Now researchers have uncovered a new clue to this mystery. The culprit: myeloperoxidase (MPO), a protein secreted by white blood cells that both signals inflammation and releases a bleach-like substance that damages the cardiovascular system.
People who have a reduced lung capacity may have a greater risk of heart attack and stroke because they show evidence of inflammation, reveals a study published online ahead of print in Thorax.